Metabolic Syndrome and Cardiovascular Risk joint with Nuclear Receptor Pathways to Metabolic Regulation Organizer(s): Bart Staels, Jean E. Schaffer and Juleen R. Zierath Date: March 27 - April 01, 2007
Location: Sheraton Steamboat Resort, Steamboat Springs, CO, USAThe metabolic syndrome is a complex entity of metabolic disorders clustering around acquired visceral obesity. These metabolic abnormalities include alterations in glucose homeostasis associated with insulin resistance, atherogenic dyslipidemia, coagulation disturbances and, in many cases, hypertension. Metabolic syndrome patients are at high risk to develop type 2 diabetes and most often die from cardiovascular diseases. Already identified in the early 1950’s and formally presented as syndrome X in the 1980’s, the metabolic syndrome is achieving epidemic proportions in the 21st century, due to global changes in life-style. In this meeting, the most recent conceptual advances in our understanding of the pathogenesis of the metabolic syndrome, its different metabolic components as well as its cardiovascular complications, will be discussed. This meeting aims to integrate approaches from basic and translational science, with an overall goal of understanding 1) how to translate this science into a more optimal lifestyle management and 2) the prospects for therapeutic intervention. Scholarship Deadline: November 27 2006 Discounted Abstract Deadline: November 27 2006 Abstract Deadline: December 28 2006 Discounted Registration Deadline: January 29 2007 We gratefully acknowledge additional support for this conference from:   We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
Merck Research Laboratories
Sanofi US
|